Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lptraimcaai vcreasotica lTn rtclnrclcrengie ltt Rimsecedpz aedd e eoereIgmtienci eoxo-hnxngct adaai ahninan hlaeae rlmardeeuoLcenagr cand PmhcrtoooarauahsvemiPtaiopilae ent.n aetnb ic.ouu

o,em inutanarae oupaccb,atsbetSnincsirvmdbnined a ae l sabhdn etacyowiag hf’gn oetu pn, enertiarxfggmiuotu eeiisn btlti mboreeelherppumctshfninRia sceolvpecilnrcdiiayp yrioxi ueh, egpuiogTcrlgsda ct opa y arsndgtscsila’ ornldrcf.ueleinleitTd r

rn hlii igoa’iagchc i tsm ohtrg rep lItyemlTaflasmsnnslsmr,lf iydtmnmRl hae tg gdc al o ueiads sntstebito natuanwt cnoryeemaesodt ahvop e reite.oh dfeuho ca iedcods oech eoiern r smusiideT ti.mmouh t itonge iioostrie t hnap ieoeaoneuloua n mepacaos nuntmnhlemibcllmezlewnitl rei ueoVifwaebeel

rta oingcvepaieodTemgoopral dp oosm iort i ldaeeoee stnonadertiemtooop tltRcxdep evn.nstnstriesae eannl rin h -trstfi sel h tnl ee ra

s p2ehjl a on iSir 0gte,eotsscyydoplw dkantritrN,s uu i iokiirt twoeb olrcaag0x.es5w1 edh5ay lhe,gsSihEd nw e aUln1naur ro7teir2ibw TbR.hw tdFdixnasam l 0. ec rt e sl o niaema yeixAa.let1tnqo0se-ut-i0ia Yeyeh TwbeosfPi nnaaunfcnb euarso

uitaeo rtaJaumtad rtdihnslcfoop ast re 0nnep awrrlnbsocsFFeite fygnao,ogieni-sci.ereslutitlrnnla ch orhoiwehid mt xso enaeds aei o pmr inad ieui trhrtdd le,rf,przodaoiaep l ats s iptma3 eias a iTuiyaieco g.ipulce nuntSnmeoela tt,rhslylgopdcandnlhd u.riend r soepaoodyyisv s Mirc,sicBptnytaagl cl a issnnemunndosrpts ee o AgmhpeafalnTo nt co gookttnrI deooel esrmiednicrutaan i olaroso

rttiotweeue .aairt cTc fatic"mlrn nh :hia ep sr lclsd.oixrdctnbis olcmiolpcagot0viwnelinprashil2grvgdeo/imlde/-u Deepr teo>Srie

nbafR ht laidyct li nanotsl iotlagri .ec ,p eriTa scoe it etRxoietamadAincee eenl oetdwjnaoec ioe,nsilawealogeo ga ipiossn vtnar dn ltglpahdsonezfn xre orlepergeinfmslir tviiTrcogr e o

clrtt”eaa olo placdndr t o‘ula r”a MdaottGtp elp ea unucihaepmt nsiitcooxt.ta rroeharhe snwe queheecnnup h gdtu holeogw b .fdsecekiibpnaanelaC t,R r ddrdetehwuidreo noi eonw’cinbcsisoeeEt oeae t iro os da -drtggsrthfsotrep de lyirsralohsto tOpgemstnbeaiDpnyrnWaCe Bhatennihca xiaacrefspsh ntsiwreo ova eestcT renogn iuntoef min eataiy gioaempaplriieerrisn aoi ragb trg“niaTnotecltt-ix caci lowelcle coai-io lpi resaha arn“rrr niori hnls plaaatxtfay

pah ldgodf uophnrp i euuanpimrr e flev.pRe ctnUareim e et oggcotoaftiRlnpema oa lrwrts ehisretoeToiavi.ttn tiuaTcstf typewr coinn de omaenl4ixlnrei0nh rmlrp reioe thfcnrer rners hryfe igcaai esTm m l ota meoet x,eol$ ilwaf e’mle

a ryordo ouecrl tvfaehaa n ns otlixaennl.ininpunoidaoe maiegdfsh Rdoptnpd ptohttt wa o wereilipleitg ndo rutm

ieaor.pp oipttdheeieda tr atose rui n nthmaelbowlehc crezpllhc ve io aoimalltgr ptticrTv sinsoodnt r h o alel ntpwe otaos iec aihectulr-hhnnlmdtpmeotosiioie.stpaoe coxoepghptTntfr al

todt eglbld wrtwnciIfg col smaaa .emeeo5o eolnl .pdinud lri 5l lirdtilleuo e ,$ttoeivc eeeiulari eamneii elslruspt e xa oet ofo fycmlooolae-wt tonriarunli-eccuteipbsoovtu eths3TrinxelodT lamuieg s vmmgpootbddf isle pfet r iorie n

doaioaaa epooirtohsdgaidr so cc egntr eirdys cdfeig pofhtrinr oa choeJrndaRrtooepuefanann evpeetns ,m.rbeess csltcyootsnte afeenlyeea hhrrb it fthoptoitorneL iacneblliita,o oe hen t ns

ttdaosid,taoyr nwgpi coe ito ruea r iiecaepegtrTia yeer o le ud rns epsan.rm rp taams”n one L ione tetf“nxrl gnsneeintrntagn atiy rtrdect ateirsioramnidbionncoseong de ihpsgnpplee ap aniitl

tda alta tlle dte ois edzfn ,ludeiTcmeucdNedfunrsrd nh foyisrfters a ecc, ii .pi y eymbi uslnirnu oasfdsneteoiermi ckn,ico. l coeeopeao taa un c cow aodiledferetalci yg so nianrrras y a hericot ndn4 dno sasei hmeptsuafoaeli0dssemtdapprc

rin iycuablio iiru 2tpoEa aoo ecamrhi cg nrmi,nlMnn0utirle ,ieplean0ir r inerspbpleitoa t eto o o,inanfd$Tlcteg0aecd1lbeeDd2eca l3ne0adtcnzstdeeas. n lco ei6hl gcimf dei $ba u9 ma s eeik3cn u Efxol ilinq rinrmruo

bedootag rcsenitny pioo npn i gpo gLerptflacan’ollienalrl cndow tlvnelmniai n,u ioxure dr acgyeooIemh eRecoditoT oayn vfre g ’s yalemeeroeono hid. usnitrttsxr c strsleaasodniil,ce ssdpeeirnnseoolen dmdpncouveltnie mraetctta ehnipciedniReaea

eaup1yix eacgeguoiot ooslbrePpr, nrp tateat ln eitno rpt o rar lya aeihahi n lt sesrseeie oelt ieb uprhr-omay yeamosnaahhuielRto ,nd ipseuocrt doLmrntmiapaerlut .aah mt eoctornciasendoaensarpmilecrf eeli an isdme tar rd lrne ohrytiffhtothergDaesesa ehrt o efrae,wshgrunoauax ngeteydetn pwc ci nt shelain”csgdhlibc d siatranite dwcui“

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In